The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial

In this study, the therapeutic efficacy of quercetin in combination with remdesivir and favipiravir, were evaluated in severe hospitalized COVID-19 patients. Our main objective was to assess the ability of quercetin for preventing the progression of the disease into critical phase, and reducing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shohan, Mojtaba, Nashibi, Roohangiz, Mahmoudian-Sani, Mohammad-Reza, Abolnezhadian, Farhad, Ghafourian, Mehri, Alavi, Seyed Mohammad, Sharhani, Asaad, Khodadadi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638148/
https://www.ncbi.nlm.nih.gov/pubmed/34863994
http://dx.doi.org/10.1016/j.ejphar.2021.174615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638148/
https://www.ncbi.nlm.nih.gov/pubmed/34863994
http://dx.doi.org/10.1016/j.ejphar.2021.174615

Ejemplares similares